Canadian DIN & Molecule SearchMolecules A–ZDrug ShortagesResourcesHealth Canada WeeklyRequest a Quote

JAMP FLECAINIDE 100 MG

FLECAINIDE ACETATE : 100 MG · DIN 02493713 · JAMP PHARMA CORPORATION

Health Canada status: MARKETED

What is JAMP FLECAINIDE?

JAMP FLECAINIDE 100 MG contains FLECAINIDE ACETATE : 100 MG. It is listed in the Health Canada Drug Product Database under DIN 02493713, held by JAMP PHARMA CORPORATION, supplied as TABLET for ORAL administration. Health Canada currently lists it as marketed, status dated 13-Nov-2020. Nexara Health is a licensed Canadian wholesale distributor (DEL 3-002896-A) and can source this product for hospitals, pharmacies and clinics. Availability and lead time are confirmed per order.

What is JAMP FLECAINIDE used for?

JAMP Flecainide is indicated for the prevention of paroxysmal supraventricular tachycardias (PSVT), including atrioventricular nodal reentrant tachycardia, atrioventricular reentrant tachycardia and other supraventricular tachycardias of unspecified mechanism, and paroxysmal atrial fibrillation/flutter (PAF). JAMP Flecainide is also indicated for the treatment of documented ventricular arrhythmias, such as sustained ventricular tachycardia (sustained VT), that in the judgement of the physician, are life-threatening.

Authorized indication as written in the Health Canada product monograph. For healthcare professionals and licensed purchasers; this is not medical advice.

Product details and regulatory record

DIN02493713
Brand nameJAMP FLECAINIDE
Generic / active ingredientFLECAINIDE ACETATE : 100 MG
ManufacturerJAMP PHARMA CORPORATION
Strength100 MG
Dosage formTABLET
Route of administrationORAL
SchedulePrescription
ATC codeC01BC04 FLECAINIDE
AHFS class24:04.04.12
BiosimilarNo
Health Canada statusMARKETED
Status date13-Nov-2020
Original market date2020-11-13 00:00:00

How is it stored and handled?

null

How is it supplied?

null

What can be used instead?

Other Canadian products sharing ATC code C01BC04 FLECAINIDE. 10 of 16 DINs in this group are currently marketed — marketed products are listed first, because that is what can actually be bought. These tables describe supply, not clinical equivalence: substitution rests with the prescriber or pharmacist, and interchangeability is determined provincially.

ProductStrengthFormManufacturerHealth Canada statusDIN
AG-FLECAINIDE100 MGTABLETANGITA PHARMA INC.MARKETEDDIN 02516071
AG-FLECAINIDE50 MGTABLETANGITA PHARMA INC.MARKETEDDIN 02516063
APO-FLECAINIDE100 MGTABLETAPOTEX INCMARKETEDDIN 02275546
APO-FLECAINIDE50 MGTABLETAPOTEX INCMARKETEDDIN 02275538
AURO-FLECAINIDE100 MGTABLETAURO PHARMA INCMARKETEDDIN 02459965
AURO-FLECAINIDE50 MGTABLETAURO PHARMA INCMARKETEDDIN 02459957
FLECAINIDE100 MGTABLETSANIS HEALTH INCMARKETEDDIN 02534819
FLECAINIDE50 MGTABLETSANIS HEALTH INCMARKETEDDIN 02534800
JAMP FLECAINIDE50 MGTABLETJAMP PHARMA CORPORATIONMARKETEDDIN 02493705
MAR-FLECAINIDE100 MGTABLETMARCAN PHARMACEUTICALS INCDORMANTDIN 02476185

Who else supplies FLECAINIDE worldwide?

Nexara tracks national medicine registries and published price lists across multiple markets. FLECAINIDE appears in 83 registered pack listings across 9 markets, published on 8 different national price bases. Where a Canadian route is closed, that is where an alternative route of supply starts — subject to the import rules in both countries.

Registered listings are not stock. Ask us to confirm what can actually be sourced for your order.

How can I get it?

Nexara Health supplies this product to licensed Canadian buyers — pharmacies, hospitals, clinics, licensed distributors, and clinical trial sponsors or their CROs. We confirm stock, pack size, expiry and pricing at the time of quotation. If the product is on backorder or in shortage, we identify equivalent alternatives and import options where permitted.

Request a quote for JAMP FLECAINIDE

Ordering questions

Who can buy this from Nexara?

Licensed entities only. Nexara holds Health Canada establishment licence DEL 3-002896-A and ships only to a licensed address.

Is there a minimum order?

Yes, set per product line and per pack multiple rather than on the order total, so you are never asked to buy a part-pack. The minimum for this line is confirmed with your quote.

What is the lead time?

Confirmed per order at quotation, and it depends on current stock position and whether the product is in shortage.

Can Nexara supply this for a clinical trial?

Yes — comparator and background-therapy supply, including sourcing from other markets where a Canadian pack will not satisfy the protocol. Clinical trial supply.

Health Canada Drug Product Database (DPD), DIN 02493713. Last reviewed 2026-09-08. Nexara Health is a licensed wholesaler and supplies licensed entities only; consumer orders are routed to a partner pharmacy.